Itinai.com stem cells therapy chaos 50 stylize 500 weir ebdc9192 9a23 4da2 aa35 12e91fb2f4b3 0
Itinai.com stem cells therapy chaos 50 stylize 500 weir ebdc9192 9a23 4da2 aa35 12e91fb2f4b3 0

Implementing a remote self-screening programme for atrial fibrillation using digital health technology among community-dwellers aged 75 years and older: a qualitative evaluation

Implementing a Remote Self-Screening Program for Atrial Fibrillation

Overview

This study evaluates how feasible it is to use digital health technology for self-screening of atrial fibrillation (AF) in older adults living in the community, specifically those aged 75 and older.

Study Design

The research involved a process evaluation of the Mass AF clinical trial, using interviews to gather insights from participants and healthcare providers.

Participants

The study included community-dwelling individuals aged 75 and older, with a balanced representation of genders and a focus on both urban and rural settings in Australia.

Intervention

Participants received handheld ECG devices and were trained to record their heart rhythms daily for at least six months. A remote team monitored their results and communicated with their general practitioners (GPs) about any findings.

Key Findings

  • High Completion Rate: 98.5% of participants completed the program.
  • Participant Satisfaction: 96% reported being satisfied with the screening process.
  • Trust in Monitoring: Participants trusted the remote monitoring system, which provided necessary follow-up.
  • Empowerment: Participants felt empowered to manage their health through self-screening.
  • GP Engagement: GPs recognized the potential to use this program for at-risk patients, enhancing patient care.

Conclusions

The remote self-screening program was successful, supported by various strengths and opportunities identified through SWOT analysis. GPs can play a crucial role in introducing this program to patients at risk of AF.

Clinical Trial Registration

Trial Registration Number: ACTRN12621000184875

Value of Clinical Trials

Clinical trials are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates clinical standards and research into an accessible resource for healthcare providers.

Streamlining Healthcare

In today’s healthcare landscape, efficiency is vital. Our mobile apps facilitate scheduling, treatment monitoring, and telemedicine, simplifying patient care management.

Enhancing Patient Outcomes

By leveraging AI, clinics can improve workflows, enhance patient outcomes, and reduce reliance on paper processes. Discover more at aidevmd.com.

AI-Powered Health Tools

Interactive AI Tools to Help You Understand Your Health

Solutions for Smart Healthcare

Clinical Research